Topics

ELSIcon2022 • Paper • June 3, 2022 Arti Singh, Michelle Nichols, Oyedunni Arulogun, Olorunyomi Olorunsogbon, Ezinne Uvere, Mayowa Ogunronbi, Joshua Akinyemi, Carolyn Jenkins, Kolawole Wahab,…

ELSIcon2022 • Paper • June 3, 2022 Kiana Amini, Vence Bonham The advent of genetic therapy technologies implicates both tremendous therapeutic promise and potential risk. Sickle cell disease…

ELSIcon2022 • Panel • June 3, 2022 Kevin Mintz, David Wasserman, Leslie Francis, and Andrew Peterson This interdisciplinary panel will advance the dialogue between disability communities and those…

ELSIcon2022 • Flash • June 3, 2022 Amy Blumling, Melanie Myers, Cindy Prows, Kristin Childers-Buschie, Michelle McGowan Background: Professional organizations have historically recommended…

ELSIcon2022 • Flash • June 3, 2022 Caroline Horrow With the promise of whole exome sequencing (WES) and whole genome sequencing (WGS), some have argued for an ethical obligation to reinterpret…

ELSIcon2022 • Flash Session 2 • June 3, 2022 Includes discussion material from Amy Blumling, Caroline Horrow, Shawn T. Sorge, Eric Anderson, and EJ Dusic.

ELSIcon2022 • Paper • June 3, 2022 Mary Majumder, Christi Guerrini, Amy McGuire, Jill Robinson, Matthew Blank, Robert Cook Deegan, Juli Bollinger, Janis Gear It is now widely acknowledged…

ELSIcon2022 • Flash • June 3, 2022 Shawn Sorge, Matthew Lebowitz Rationale: Addictive disorders are increasingly conceptualized as having a genetic basis. Personalized genetic information is…

ELSIcon2022 • Paper • June 3, 2022 Roselle Ponsaran, Kyle B. Brothers, Aaron Goldenberg, Jean Cadigan The promotion of precision medicine has led to increased interest in larger collections…

ELSIcon2022 • Paper Session 13 • June 3, 2022 Includes discussion material from Kayte Spector-Bagdady, Arti Singh, Roselle Ponsaran, and Mary Majumder.